These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33419682)

  • 1. The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited.
    Deek MP; Van der Eecken K; Phillips R; Parikh NR; Isaacsson Velho P; Lotan TL; Kishan AU; Maurer T; ; Boutros PC; Hovens C; Abramowtiz M; Pollack A; Desai N; Stish B; Feng FY; Eisenberger M; Carducci M; Pienta KJ; Markowski M; Paller CJ; Antonarakis ES; Berlin A; Ost P; Tran PT
    Eur Urol; 2021 Nov; 80(5):632-640. PubMed ID: 33419682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment.
    Hoang T; Sutera P; Nguyen T; Chang J; Jagtap S; Song Y; Shetty AC; Chowdhury DD; Chan A; Carrieri FA; Hathout L; Ennis R; Jabbour SK; Parikh R; Molitoris J; Song DY; DeWeese T; Marchionni L; Ren L; Sawant A; Simone N; Lafargue A; Van Der Eecken K; Bunz F; Ost P; Tran PT; Deek MP
    Prostate; 2024 Jan; 84(1):87-99. PubMed ID: 37812042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.
    Sutera P; Van Der Eecken K; Kishan AU; Hamid A; Grist E; Attard G; Lotan T; Mendes AA; Paller CJ; Carducci MA; Ross A; Wang H; Pienta K; Feng FY; Antonarakis ES; Ost P; Song DY; Greco S; Deville C; DeWeese T; Tran PT; Deek MP
    Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):713-719. PubMed ID: 35013522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
    Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
    Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer.
    Sutera P; Song Y; Shetty AC; English K; Van der Eecken K; Guler OC; Wang J; Cao Y; Bazyar S; Verbeke S; Van Dorpe J; Fonteyne V; De Laere B; Mishra M; Rana Z; Molitoris J; Ferris M; Kiess A; Song DY; DeWeese T; Pienta KJ; Barbieri C; Marchionni L; Ren L; Sawant A; Simone N; Berlin A; Onal C; Tran PT; Ost P; Deek MP
    Eur Urol Oncol; 2024 Jun; ():. PubMed ID: 38862340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration-Sensitive Prostate Cancer.
    Wei Y; Wu J; Gu W; Wang J; Lin G; Qin X; Dai B; Gan H; Ye D; Zhu Y
    Oncologist; 2020 Jul; 25(7):e1042-e1050. PubMed ID: 32190957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non-Small Cell Lung Cancer.
    Liao R; Chen K; Li J; He H; Yi G; Huang M; Chen R; Shen L; Zhang X; Xu Z; Yang Z; Peng Y
    Cancer Res Treat; 2023 Jul; 55(3):814-831. PubMed ID: 36634615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer.
    Sutera P; Kim J; Kumar R; Deek RA; Stephenson R; Mayer T; Saraiya B; Ghodoussipour S; Jang T; Golombos D; Packiam V; Ennis R; Hathout L; Jabbour SK; Guler O; Onal C; Tran PT; Deek MP
    Prostate; 2024 Oct; 84(14):1301-1308. PubMed ID: 39021052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.
    Isaacsson Velho P; Qazi F; Hassan S; Carducci MA; Denmeade SR; Markowski MC; Thorek DL; DeWeese TL; Song DY; Tran PT; Eisenberger MA; Antonarakis ES
    Eur Urol; 2019 Aug; 76(2):170-176. PubMed ID: 30293905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer.
    Swami U; Isaacsson Velho P; Nussenzveig R; Chipman J; Sacristan Santos V; Erickson S; Dharmaraj D; Alva AS; Vaishampayan UN; Esther J; Hahn AW; Maughan BL; Antonarakis ES; Agarwal N
    Eur Urol; 2020 Nov; 78(5):652-656. PubMed ID: 32624276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
    Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
    Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer.
    Sutera P; Shetty AC; Song Y; Hodges T; Hoang T; Rana Z; Pienta K; Feng F; Song DY; DeWeese T; Gillessen S; Sweeney C; James N; Attard G; Deek M; Tran PT
    Eur Urol Oncol; 2024 Apr; 7(2):241-247. PubMed ID: 37558543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
    Antonarakis ES; Lu C; Luber B; Liang C; Wang H; Chen Y; Silberstein JL; Piana D; Lai Z; Chen Y; Isaacs WB; Luo J
    Eur Urol; 2018 Aug; 74(2):218-225. PubMed ID: 29439820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients.
    Cussenot O; Timms KM; Perrot E; Blanchet P; Brureau L; Solimeno C; Fromont G; Comperat E; Cancel-Tassin G
    Eur Urol Oncol; 2024 Jun; 7(3):597-604. PubMed ID: 38182487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.
    Lin E; Hahn AW; Nussenzveig RH; Wesolowski S; Sayegh N; Maughan BL; McFarland T; Rathi N; Sirohi D; Sonpavde G; Swami U; Kohli M; Rich T; Sartor O; Yandell M; Agarwal N
    Oncologist; 2021 Sep; 26(9):751-760. PubMed ID: 34157173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer.
    Kohli M; Tan W; Zheng T; Wang A; Montesinos C; Wong C; Du P; Jia S; Yadav S; Horvath LG; Mahon KL; Kwan EM; Fettke H; Yu J; Azad AA
    EBioMedicine; 2020 Apr; 54():102728. PubMed ID: 32268276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Mutational Landscape Linked with Pre-Docetaxel Lactate Dehydrogenase Levels Predicts Docetaxel Response in Metastatic Castrate-Resistant Prostate Cancer.
    Hiew K; Hart CA; Ali A; Elliott T; Ramani V; Sangar V; Lau M; Maddineni S; Brown M; Clarke N
    Eur Urol Focus; 2019 Sep; 5(5):831-841. PubMed ID: 29699892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer.
    Deek MP; Taparra K; Phillips R; Velho PI; Gao RW; Deville C; Song DY; Greco S; Carducci M; Eisenberger M; DeWeese TL; Denmeade S; Pienta K; Paller CJ; Antonarakis ES; Olivier KR; Park SS; Tran PT; Stish BJ
    Eur Urol Oncol; 2021 Jun; 4(3):447-455. PubMed ID: 32536574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer.
    Sutera P; Deek MP; Van der Eecken K; Shetty AC; Chang JH; Hodges T; Song Y; Verbeke S; Van Dorpe J; Fonteyne V; De Laere B; Mishra M; Rana Z; Molitoris J; Ferris M; Ross A; Schaeffer E; Roberts N; Song DY; DeWeese T; Pienta KJ; Antonarakis ES; Ost P; Tran PT
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1095-1101. PubMed ID: 36708787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer.
    Sutera P; Song Y; Van der Eecken K; Shetty AC; English K; Hodges T; Chang J; Fonteyne V; Rana Z; Ren L; Mendes AA; Lumen N; Delrue L; Verbeke S; De Man K; Song DY; Pienta K; Feng FY; Joniau S; Lotan T; Lane B; Kiess A; Rowe S; Pomper M; DeWeese T; Deek M; Sweeney C; Ost P; Tran PT
    Eur Urol; 2023 Dec; 84(6):531-535. PubMed ID: 37173210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.